Elong Power Holding Limited Announces Closing of US$6.6 Million Public Offering

Elong Power Holding Limited Announces Closing of US$6.6 Million Public Offering

BEIJING, July 14, 2026 /PRNewswire/ -- Elong Power Holding Limited (Nasdaq: ELPW) ("Elong Power" or the "Company"), a comprehensive provider dedicated to the R&D, sales and scenario-oriented system solutions of lithium-ion battery energy storage...

Delonix Bioworks Announces First Participant Dosed in Phase 1 Clinical Trial of Next-Generation MenB OMV Vaccine DX-104 in China

Delonix Bioworks Announces First Participant Dosed in Phase 1 Clinical Trial of Next-Generation MenB OMV Vaccine DX-104 in China

SHANGHAI, July 13, 2026 /PRNewswire/ -- Delonix Bioworks, a clinical-stage biotechnology company pioneering genetically engineered bacterial vaccines, today announced that the first participant has been dosed in its Phase 1 clinical trial of DX-104...

Leads Biolabs Announces Multiple Studies Selected for ESMO 2026, Highlighting the Growing Global Competitiveness of Its Core Pipeline

Leads Biolabs Announces Multiple Studies Selected for ESMO 2026, Highlighting the Growing Global Competitiveness of Its Core Pipeline

NANJING, China, July 13, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced that six of its latest research studies have been accepted for presentation at the 2026 European...

OlloBot Reveals OlloNi SS1's New Identity Design and Announces Ollo-Family Blind Box Launch at Houston Pop-Up This July

OlloBot Reveals OlloNi SS1's New Identity Design and Announces Ollo-Family Blind Box Launch at Houston Pop-Up This July

NEW YORK, July 10, 2026 /PRNewswire/ -- OlloBot unveiled the core upgrades of the OlloNi SS1, marking a comprehensive leap forward in design and AI capabilit for its highly anticipated family companion cyber-pet robot. At the same time, OlloBot has...

e& Announces USD 5.95 Billion Sale of Vodafone Investment

e& Announces USD 5.95 Billion Sale of Vodafone Investment

ABU DHABI, UAE, July 10, 2026 /PRNewswire/ -- Following a comprehensive strategic review of its international investment portfolio, Emirates Telecommunications Group Company PJSC ("e&") announced the termination of its Relationship Agreement...

Infiniti Indah Announces the Return of Pesta Kuantan 188 from 31 July to 2 August.

Infiniti Indah Announces the Return of Pesta Kuantan 188 from 31 July to 2 August.

Bringing 14 Exciting Event Experiences for the People Expecting to draw more than 100,000 local, domestic and international visitors KUANTAN, Malaysia, July 9, 2026 /PRNewswire/ -- Infiniti Indah Sdn. Bhd. (Kuantan 188), a subsidiary of Trinidad...

InxMed Announces Publication in The Lancet Respiratory Medicine Featuring Promising Anticancer Activity of Ifebemtinib in combination with Garsorasib in First-Line non-small cell lung cancer (NSCLC) Harboring KRAS G12C Mutation

InxMed Announces Publication in The Lancet Respiratory Medicine Featuring Promising Anticancer Activity of Ifebemtinib in combination with Garsorasib in First-Line non-small cell lung cancer (NSCLC) Harboring KRAS G12C Mutation

NANJING, China, July 9, 2026 /PRNewswire/ -- InxMed Co., Ltd ("InxMed"), a clinical-stage biotechnology company dedicated to developing innovative therapies targeting cancer treatment resistance and metastasis, today announced that the clinical...

RoboSense Announces H1 2026 LiDAR Sales of 719,200 Units as Robotics Segment Grows by 510.4%

RoboSense Announces H1 2026 LiDAR Sales of 719,200 Units as Robotics Segment Grows by 510.4%

RoboSense recorded 719,200 units in LiDAR sales in H1 2026, up 169.6% year over year, with robotics LiDAR sales surging 510.4% to 282,600 units. In Q2 2026, RoboSense recorded 388,900 units in LiDAR sales, including 97,100 units from robotics...

Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Trial of LNK01004 Ointment for Vitiligo

Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Trial of LNK01004 Ointment for Vitiligo

HANGZHOU, China, SHANGHAI and BOSTON, July 9, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, today announced that the...

Pop Culture Group Co., Ltd Announces 10 for 1 Share Consolidation

Pop Culture Group Co., Ltd Announces 10 for 1 Share Consolidation

XIAMEN, China, July 9, 2026 /PRNewswire/ -- Pop Culture Group Co., Ltd (NASDAQ: CPOP) (the "Company"), today announced that it will effect a share consolidation of its Class A ordinary shares of par value US$0.01 each (the "Class A Ordinary...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 85
  • menu
    menu